{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:19:47Z","timestamp":1781644787539,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-03879-8","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T13:36:11Z","timestamp":1738935371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic implications of baricitinib in mouse model of vitiligo"],"prefix":"10.1007","volume":"317","author":[{"given":"Harjot","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanika","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davinder","family":"Parsad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravinder","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"issue":"1","key":"3879_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1755-148X.2011.00916.x","volume":"25","author":"JA Mosenson","year":"2012","unstructured":"Mosenson JA, Zloza A, Klarquist J, Barfuss AJ, Guevara-Patino JA, Poole IC (2012) HSP70i is a critical component of the immune response leading to vitiligo. Pigment Cell Melanoma Res 25(1):88\u201398. https:\/\/doi.org\/10.1111\/j.1755-148X.2011.00916.x","journal-title":"Pigment Cell Melanoma Res"},{"issue":"1","key":"3879_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jdermsci.2015.09.003","volume":"81","author":"H Xie","year":"2016","unstructured":"Xie H, Zhou F, Liu L, Zhu G, Li Q, Li C, Gao T (2016) Vitiligo: how do oxidative stress-induced autoantigens trigger autoimmunity? J Dermatol Sci 81(1):3\u20139. https:\/\/doi.org\/10.1016\/j.jdermsci.2015.09.003","journal-title":"J Dermatol Sci"},{"key":"3879_CR3","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00403-016-1690-3","volume":"308","author":"Y Zhen","year":"2016","unstructured":"Zhen Y, Yao L, Zhong S, Song Y, Cui Y, Li S (2016) Enhanced Th1 and Th17 responses in peripheral blood in active non-segmental vitiligo. Arch Dermatol Res 308:703\u2013710. https:\/\/doi.org\/10.1007\/s00403-016-1690-3","journal-title":"Arch Dermatol Res"},{"key":"3879_CR4","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","volume":"188","author":"GS Ogg","year":"1998","unstructured":"Ogg GS, Rod Dunbar P, Romero P, Chen JL, Cerundolo V (1998) High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J Exp Med 188:1203\u20131208. https:\/\/doi.org\/10.1084\/jem.188.6.1203","journal-title":"J Exp Med"},{"key":"3879_CR5","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jaad.2016.12.021","volume":"76","author":"JP Strassner","year":"2017","unstructured":"Strassner JP, Rashighi M, Refat MA, Richmond JM, Harris JE (2017) Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity. J Am Acad Dermatol 76:847\u2013855. https:\/\/doi.org\/10.1016\/j.jaad.2016.12.021","journal-title":"J Am Acad Dermatol"},{"issue":"11\u201312","key":"3879_CR6","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1080\/10715762.2017.1402303","volume":"51","author":"S Mitra","year":"2017","unstructured":"Mitra S, De Sarkar S, Pradhan A, Pati AK, Pradhan R, Mondal D, Sen S, Ghosh A, Chatterjee S, Chatterjee M (2017) Levels of oxidative damage and proinflammatory cytokines are enhanced in patients with active vitiligo. Free Radic Res 51(11\u201312):986\u2013994. https:\/\/doi.org\/10.1080\/10715762.2017.1402303","journal-title":"Free Radic Res"},{"issue":"2","key":"3879_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/1744666X.2019.1550358","volume":"15","author":"M Singh","year":"2019","unstructured":"Singh M, Kotnis A, Jadeja SD, Mondal A, Mansuri MS, Begum R (2019) Cytokines: the yin and yang of vitiligo pathogenesis. Expert Rev Clin Immunol 15(2):177\u2013188. https:\/\/doi.org\/10.1080\/1744666X.2019.1550358","journal-title":"Expert Rev Clin Immunol"},{"issue":"4","key":"3879_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/exd.12103","volume":"22","author":"NC Laddha","year":"2013","unstructured":"Laddha NC, Dwivedi M, Mansuri MS, Gani AR, Ansarullah M, Ramachandran AV, Dalai S, Begum R (2013) Vitiligo: interplay between oxidative stress and immune system. Exp Dermatol 22(4):245\u2013250. https:\/\/doi.org\/10.1111\/exd.12103","journal-title":"Exp Dermatol"},{"issue":"4","key":"3879_CR9","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.jid.2021.09.015","volume":"142","author":"C Martins","year":"2022","unstructured":"Martins C, Migayron L, Drullion C, Jacquemin C, Lucchese F, Rambert J, Merhi R, Michon P, Taieb A, Rezvani HR, de Rinaldis E (2022) Vitiligo skin T cells are prone to produce type 1 and type 2 cytokines to induce melanocyte dysfunction and epidermal inflammatory response through Jak signaling. J Invest Dermatol 142(4):1194\u20131205. https:\/\/doi.org\/10.1016\/j.jid.2021.09.015","journal-title":"J Invest Dermatol"},{"key":"3879_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.freeradbiomed.2019.05.011","volume":"139","author":"X Chen","year":"2019","unstructured":"Chen X, Guo W, Chang Y, Chen J, Kang P, Yi X, Cui T, Guo S, Xiao Q, Jian Z, Li K (2019) Oxidative stress-induced IL-15 trans-presentation in keratinocytes contributes to CD8+ T cells activation via JAK-STAT pathway in vitiligo. Free Radic Biol Med 139:80\u201391. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.05.011","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"3879_CR11","doi-asserted-by":"publisher","first-page":"5298","DOI":"10.4049\/jimmunol.0902819","volume":"184","author":"JS Fridman","year":"2010","unstructured":"Fridman JS, Scherle PA, Collins R, Burn TC, Li Y, Li J, Covington MB, Thomas B, Collier P, Favata MF, Wen X (2010) Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050. J Immunol 184(9):5298\u20135307. https:\/\/doi.org\/10.4049\/jimmunol.0902819","journal-title":"J Immunol"},{"key":"3879_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.650708","volume":"12","author":"C Dang","year":"2021","unstructured":"Dang C, Lu Y, Chen X, Li Q (2021) Baricitinib ameliorates experimental autoimmune encephalomyelitis by modulating the Janus kinase\/signal transducer and activator of transcription signaling pathway. Front Immunol 12:650708. https:\/\/doi.org\/10.3389\/fimmu.2021.650708","journal-title":"Front Immunol"},{"key":"3879_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.704526","volume":"12","author":"J Lee","year":"2021","unstructured":"Lee J, Park Y, Jang SG, Hong SM, Song YS, Kim MJ, Baek S, Park SH, Kwok SK (2021) Baricitinib attenuates autoimmune phenotype and podocyte injury in a murine model of systemic lupus erythematosus. Front Immunol 12:704526. https:\/\/doi.org\/10.3389\/fimmu.2021.704526","journal-title":"Front Immunol"},{"issue":"5","key":"3879_CR14","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/ptr.5794","volume":"31","author":"SX Huo","year":"2017","unstructured":"Huo SX, Wang Q, Liu XM, Ge CH, Gao L, Peng XM, Yan M (2017) The effect of butin on the vitiligo mouse model induced by hydroquinone. Phytother Res 31(5):740\u2013746. https:\/\/doi.org\/10.1002\/ptr.5794","journal-title":"Phytother Res"},{"issue":"11","key":"3879_CR15","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1038\/s41375-018-0123-z","volume":"32","author":"J Choi","year":"2018","unstructured":"Choi J, Cooper ML, Staser K, Ashami K, Vij KR, Wang B, Marsala L, Niswonger J, Ritchey J, Alahmari B, Achilefu S (2018) Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease. Leukemia 32(11):2483\u20132494. https:\/\/doi.org\/10.1038\/s41375-018-0123-z","journal-title":"Leukemia"},{"key":"3879_CR16","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s40495-018-0151-4","volume":"4","author":"CJ Malemud","year":"2018","unstructured":"Malemud CJ (2018) Defective JAK-STAT pathway signaling contributes to autoimmune diseases. Curr Pharmacol Rep 4:358\u2013366. https:\/\/doi.org\/10.1007\/s40495-018-0151-4","journal-title":"Curr Pharmacol Rep"},{"key":"3879_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.104119","volume":"80","author":"PM Elhalmoushy","year":"2023","unstructured":"Elhalmoushy PM, Elsheikh MA, Matar NA, El-Hadidy WF, Kamel MA, Omran GA, Elnaggar YS (2023) Elaboration of novel gel-core oleosomes encapsulating phytoconstituent for targeted topical delivery in a vitiligo-induced mouse model: Focus on antioxidant and anti-inflammatory pathways. J Drug Deliv Sci Technol 80:104119. https:\/\/doi.org\/10.1016\/j.jddst.2022.104119","journal-title":"J Drug Deliv Sci Technol"},{"key":"3879_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121523","volume":"615","author":"PM Elhalmoushy","year":"2022","unstructured":"Elhalmoushy PM, Elsheikh MA, Matar NA, El-Hadidy WF, Kamel MA, Omran GA, Elnaggar YS (2022) Novel berberine-loaded hyalurosomes as a promising nanodermatological treatment for vitiligo: biochemical, biological and gene expression studies. Int J Pharm 615:121523. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.121523","journal-title":"Int J Pharm"},{"issue":"7","key":"3879_CR19","doi-asserted-by":"publisher","first-page":"4859","DOI":"10.1007\/s00210-023-02917-4","volume":"397","author":"K Chauhan","year":"2024","unstructured":"Chauhan K, Goel F, Singh S (2024) Apigenin protects melanocytes and improve tyrosinase activity in a hydroquinone induced vitiligo mouse model targeting P38 MAP kinase signaling: histopathology and immunohistochemistry analysis. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 397(7):4859\u20134869. https:\/\/doi.org\/10.1007\/s00210-023-02917-4","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"issue":"9","key":"3879_CR20","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1038\/jid.2009.32","volume":"129","author":"JG Van Den Boorn","year":"2009","unstructured":"Van Den Boorn JG, Konijnenberg D, Dellemijn TA, Van Der Veen JW, Bos JD, Melief CJ, Vyth-Dreese FA, Luiten RM (2009) Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Investig Dermatol 129(9):2220\u20132232. https:\/\/doi.org\/10.1038\/jid.2009.32","journal-title":"J Investig Dermatol"},{"issue":"4","key":"3879_CR21","first-page":"1219","volume":"148","author":"IC Le Poole","year":"1996","unstructured":"Le Poole IC, van den Wijngaard RM, Westerhof W, Das PK (1996) Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol 148(4):1219\u20131228","journal-title":"Am J Pathol"},{"issue":"1","key":"3879_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/cei.12146","volume":"174","author":"S You","year":"2013","unstructured":"You S, Cho YH, Byun JS, Shin EC (2013) Melanocyte-specific CD8+ T cells are associated with epidermal depigmentation in a novel mouse model of vitiligo. Clin Exp Immunol 174(1):38\u201344. https:\/\/doi.org\/10.1111\/cei.12146","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"3879_CR23","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jid.2018.10.032","volume":"139","author":"JM Richmond","year":"2019","unstructured":"Richmond JM, Strassner JP, Rashighi M, Agarwal P, Garg M, Essien KI, Pell LS, Harris JE (2019) Resident memory and recirculating memory T cells cooperate to maintain disease in a mouse model of vitiligo. J Investig Dermatol 139(4):769\u2013778. https:\/\/doi.org\/10.1016\/j.jid.2018.10.032","journal-title":"J Investig Dermatol"},{"issue":"5","key":"3879_CR24","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/pcmr.12962","volume":"34","author":"N Pervaiz","year":"2021","unstructured":"Pervaiz N, Kaur H, Parsad D, Kumar R (2021) Immune-modulatory effects of lenalidomide inhibited the progression of lesions in a vitiligo mouse model. Pigment Cell Melanoma Res 34(5):918\u2013927. https:\/\/doi.org\/10.1111\/pcmr.12962","journal-title":"Pigment Cell Melanoma Res"},{"key":"3879_CR25","doi-asserted-by":"publisher","first-page":"1324892","DOI":"10.3389\/fphar.2024.1324892","volume":"15","author":"S Chen","year":"2024","unstructured":"Chen S, Li C, Tu Z, Cai T, Zhang X, Wang L, Tian R, Huang J, Gong Y, Yang X, Wu Z (2024) Off-label use of Baricitinib improves moderate and severe atopic dermatitis in China through inhibiting MAPK and PI3K\/Akt\/mTOR pathway via targeting JAK-STAT signaling of CD4+ cells. Front Pharmacol 15:1324892. https:\/\/doi.org\/10.3389\/fphar.2024.1324892","journal-title":"Front Pharmacol"},{"issue":"2","key":"3879_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1034\/j.1600-0749.2002.1o049.x","volume":"15","author":"S Moretti","year":"2002","unstructured":"Moretti S, Spallanzani A, Amato L, Hautmann G, Gallerani I, Fabiani M, Fabbri P (2002) New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res 15(2):87\u201392. https:\/\/doi.org\/10.1034\/j.1600-0749.2002.1o049.x","journal-title":"Pigment Cell Res"},{"key":"3879_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00403-019-01996-9","volume":"312","author":"N Gholijani","year":"2020","unstructured":"Gholijani N, Yazdani MR, Dastgheib L (2020) Predominant role of innate pro-inflammatory cytokines in vitiligo disease. Arch Dermatol Res 312:123\u2013131. https:\/\/doi.org\/10.1007\/s00403-019-01996-9","journal-title":"Arch Dermatol Res"},{"issue":"12","key":"3879_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052298","volume":"7","author":"NC Laddha","year":"2012","unstructured":"Laddha NC, Dwivedi M, Begum R (2012) Increased Tumor Necrosis Factor (TNF)-\u03b1 and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo. PLoS ONE 7(12):e52298. https:\/\/doi.org\/10.1371\/journal.pone.0052298","journal-title":"PLoS ONE"},{"key":"3879_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2165\/00128071-200203050-00001","volume":"3","author":"CL Huang","year":"2002","unstructured":"Huang CL, Nordlund JJ, Boissy R (2002) Vitiligo: a manifestation of apoptosis. Am J Clin Dermatol 3:301\u2013308. https:\/\/doi.org\/10.2165\/00128071-200203050-00001","journal-title":"Am J Clin Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-03879-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-03879-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-03879-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T13:36:14Z","timestamp":1738935374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-03879-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3879"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-03879-8","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflit of interest"}},{"value":"The study was approved by Institutional Animal Ethics Committee (PU\/45\/99\/CPCSEA\/IAEC\/2020\/423). The experimental protocols were carried out in accordance with the regulations set by Committee for Control and Supervision of Experiments on Animals for the Purpose of Scientific Research (CCSEA).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"353"}}